In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...

GlaxoSmithKline's big gamble on Merck KGaA's bintrafusp alfa has gone from bad to worse, after the drug failed yet another mid-stage trial. The latest disappointment has come from the phase 2 INTR ...

Kepler Capital analyst David Evans maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) on October 30 and set a price ...

At GlaxoSmithKline, we never lose sight of the fact that patients are at the core of what we do and that millions of lives are impacted by cancer. The patient’s voice is at the heart of our ...

Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...

The "Over the Counter (OTC) Drugs - Market Insight, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The global Over-the-Counter (OTC) drugs market is ...

Legal experts say the tax indemnification clauses can be invoked by HUL against the seller GlaxoSmithKline in case of any unexpected tax outgo due to the transaction. Since the proceeds were ...

The significance and reach of the collaboration has gone well beyond the initial aims. Professor Harry A Kelly, Collaborative Programme Director, GlaxoSmithKline The University of Strathclyde and ...

The global glucosamine supplement market is projected to grow from USD 583.6 million in 2023 to USD 932.7 million by 2033, expanding at a CAGR of 4.8%, according to Future Market Insights. The rising ...